Law Offices of Howard G. Smith announces an investigation on behalf of investors of Sunesis Pharmaceuticals, Inc. ("Sunesis" or the "Company") (NASDAQ: SNSS). The investigation concerns whether the Company violated specific sections of the Securities Exchange Act of 1934 by issuing materially misleading information to the investing public. Investors who have lost over $50,000 on their Sunesis investment are encouraged to contact the Law Offices of Howard G. Smith.

On July 23, 2015, Sunesis announced that the United States Food and Drug Administration will not approve its blood cancer drug Qinprezo based on available data, and that the Company must provide more clinical evidence supporting approval of Qinprezo. On this news, shares of Sunesis fell $2.25 per share, or more than 70%, during intraday trading on July 24, 2015. Investors have been damaged by the alleged fraud of the Company and the Law Offices of Howard G. Smith is preparing a complaint to seek compensation on behalf of investors.

If you purchased Sunesis shares, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com

Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Sunesis Pharmaceuticals Charts.
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Sunesis Pharmaceuticals Charts.